GIANNELLA, Mario
 Distribuzione geografica
Continente #
NA - Nord America 249
EU - Europa 86
AS - Asia 21
AF - Africa 3
SA - Sud America 2
Totale 361
Nazione #
US - Stati Uniti d'America 248
IT - Italia 43
VN - Vietnam 13
FR - Francia 12
CZ - Repubblica Ceca 8
PL - Polonia 6
DE - Germania 4
NL - Olanda 3
RU - Federazione Russa 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
UA - Ucraina 2
AT - Austria 1
CN - Cina 1
FI - Finlandia 1
HN - Honduras 1
IE - Irlanda 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
MT - Malta 1
RO - Romania 1
SG - Singapore 1
TW - Taiwan 1
Totale 361
Città #
Camerino 28
Fairfield 28
Ashburn 23
Houston 19
Santa Cruz 16
Seattle 16
Wilmington 16
Woodbridge 14
Cambridge 12
Dong Ket 12
Buffalo 6
Centro 6
Warsaw 6
Las Vegas 5
Florence 4
Chicago 3
Clearwater 3
Los Angeles 3
Ann Arbor 2
Boardman 2
Council Bluffs 2
Dallas 2
Frankfurt am Main 2
Muizenberg 2
New York 2
Recife 2
Scafati 2
Amsterdam 1
Ascoli Piceno 1
Baghdad 1
Camden 1
Dublin 1
Elk Grove Village 1
Fayetteville 1
Hefei 1
Helsinki 1
Ho Chi Minh City 1
L-Iklin 1
Lake Forest 1
McHenry 1
Milpitas 1
Parsippany 1
Pittsburgh 1
Portland 1
Provo 1
Pune 1
Remington 1
Reston 1
Rochester 1
Rome 1
Saint Petersburg 1
San Diego 1
San Jose 1
Scarsdale 1
Silverton 1
Taipei 1
Tucson 1
Totale 268
Nome #
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease, file e0ff0074-3e75-9bac-e053-1705fe0af019 157
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold, file e0ff0074-619a-9bac-e053-1705fe0af019 77
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation, file e0ff0072-8ce2-9bac-e053-1705fe0af019 71
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia, file e0ff0075-1649-9bac-e053-1705fe0af019 25
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells, file e0ff0074-2b92-9bac-e053-1705fe0af019 9
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation, file e0ff0074-4c03-9bac-e053-1705fe0af019 8
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation, file e0ff0073-8b02-9bac-e053-1705fe0af019 4
Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions, file 09e75f56-4140-46d3-a5bb-51c2423ab1f9 3
The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of Oxaliplatin-Induced Neurotoxicity, file df079acd-71c5-4d1e-b622-27d399e4b29f 2
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement., file e0ff0072-468a-9bac-e053-1705fe0af019 2
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition, file e0ff0072-70db-9bac-e053-1705fe0af019 2
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect, file e0ff0072-70e1-9bac-e053-1705fe0af019 2
Might the observed alpha2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations?, file e0ff0072-7ad9-9bac-e053-1705fe0af019 2
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes, file e0ff0074-3cba-9bac-e053-1705fe0af019 2
Alpha2C-adrenoceptor modulators: a patent review, file e0ff0072-70e3-9bac-e053-1705fe0af019 1
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway, file e0ff0072-7ad6-9bac-e053-1705fe0af019 1
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists, file e0ff0072-7adc-9bac-e053-1705fe0af019 1
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes, file e0ff0072-b98a-9bac-e053-1705fe0af019 1
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision, file e0ff0072-e565-9bac-e053-1705fe0af019 1
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia, file e0ff0074-49a0-9bac-e053-1705fe0af019 1
Totale 372
Categoria #
all - tutte 1.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.329


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 0 0 4 9
2020/2021149 8 24 6 21 13 12 11 7 11 8 9 19
2021/202280 11 2 2 5 4 6 0 2 5 4 24 15
2022/202366 4 4 21 10 4 3 1 3 2 5 7 2
2023/202448 1 1 4 6 6 7 4 10 3 6 0 0
Totale 372